Cradle
cradle.bio | Biotech, AI
Year2022
RoundSeed
Amount$5.5M
Overall
1 slide
Introducing a transformative way to design better proteins.
1 slide
Our team synergizes biology, machine learning, and design expertise, founded in October 2021 and based in Delft and Zurich.
2 slides
Designing and engineering proteins is extremely challenging and currently inefficient, with a mere 1-5% success rate in experiments.
2 slides
Cradle's algorithms significantly enhance protein design by learning from each experimental round, unlike traditional methods.
2 slides
Teams can independently use Cradle to accelerate the design/build/test cycle of novel proteins, achieving results faster.
2 slides
Cradle operates on a SaaS model with a subscription-based software and future bio-services, ensuring privacy and IP ownership for users.
2 slides
Cradle reduces the cost and time to develop protein-based products, improves hit rates, and accelerates innovation through machine learning methods.
3 slides
Our in-house examples show significant improvements in protein stability and effectiveness, validated by leaders in the industry.
1 slide
Thank you.
